XTX Topco’s Organogenesis Holdings ORGO Stock Holding History

XTX Topco’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$447K	Buy	+183,760	New	+$449K	0.01%	2560
2026 Q1	–	Sell	-15,311	Closed	-$79.3K	–	4222
2025 Q4	$79.3K	Buy	+15,311	New	+$74.2K	﹤0.01%	2701
2025 Q2	–	Sell	-74,208	Closed	-$321K	–	2951
2025 Q1	$321K	Buy	74,208 +1,036	+1%	+$4.18K	0.02%	1354
2024 Q4	$234K	Buy	+73,172	New	+$246K	0.02%	1428
2024 Q2	–	Sell	-43,584	Closed	-$124K	–	2314
2024 Q1	$124K	Sell	43,584 -35,946	-45%	-$122K	0.02%	1317
2023 Q4	$325K	Buy	+79,530	New	+$223K	0.07%	557
2023 Q3	–	Sell	-98,602	Closed	-$327K	–	1890
2023 Q2	$327K	Sell	98,602 -196,498	-67%	-$581K	0.06%	651
2023 Q1	$629K	Buy	295,100 +77,962	+36%	+$193K	0.13%	189
2022 Q4	$584K	Buy	217,138 +63,732	+42%	+$186K	0.12%	234
2022 Q3	$497K	Buy	+153,406	New	+$693K	0.12%	242
2022 Q2	–	Sell	-17,602	Closed	-$134K	–	1034
2022 Q1	$134K	Buy	+17,602	New	+$136K	0.06%	474

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

XTX Topco's ORGO Position: Q2 2026 in Review

XTX Topco opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 183,760 shares worth $447K. The stake represents 0.01% of the portfolio and ranks #2560 among its holdings. This is a return to the name: XTX Topco previously reported a position in ORGO as recently as Q4 2025.

XTX Topco first reported a position in ORGO in Q1 2022 and has held it in 11 quarters since. The position peaked at $629K in Q1 2023. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

XTX Topco held 183,760 shares of Organogenesis Holdings worth $447K as of Q2 2026.
Organogenesis Holdings was a new XTX Topco position in Q2 2026.
Organogenesis Holdings made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2560 holding.
XTX Topco first reported a position in Organogenesis Holdings in Q1 2022 and has held it in 11 quarters since.
XTX Topco's Organogenesis Holdings position peaked at $629K in Q1 2023.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.